Aug. 13, 2018
As U.S. obesity rates climb and Americans age, more people are developing sleep apnea, restless leg syndrome and other sleep disorders. Plus, stressors related to the volatile stock market, terrorism, mass shootings, healthcare, student debt, and protests against politicians are all resulting in more sleepless nights. As a result, a huge industry has emerged to analyze and treat America’s insomniacs—sleep lab and home test devices, CPAP masks, premium mattresses and pillows, Rx and OTC sleep medications, apps, sound machines and more.
An estimated 70 million Americans have insomnia, and 43 million suffer from obstructive sleep apnea (OSA), mostly undiagnosed. As obesity rates remain high, this problem is not likely to dissipate any time soon. Therefore, there is ample room for future growth of CPAP devices, sleep studies, OTC and prescription medications, and other services.
- The U.S. “sleep market” was worth an estimated $28.6 billion in 2017. For 2018, the market should grow by 3.3%. To 2023, 4.7% average annual growth is forecast.
- The major prescription insomnia drugs market, led by Belsomra, Ambien, and Lunesta, has been declining in value due to the expiration of patents and the entry of cheaper generics. These drugs’ U.S. sales total about $1.4 billion. However, the non-prescription or OTC sleeping pills market, valued at $576 million, is growing faster.
- Sleep Labs – There are an estimated 4,700 U.S. sleep centers or labs which perform studies (polysomnograms) to diagnose sleep disorders. The typical lab has revenues of $920,000 and a bed count of about 7-8. Labs are located in hospitals, MD practices, universities, or are independent. This segment was worth $4.3 billion in 2017. There has been consolidation and closures due to reimbursement pressure from competing portable home testing devices approved by Medicare.
- The huge $16 billion mattress market is undergoing transformation, as technology changes the materials mattresses are made of, and the major retailers merge. E-commerce upstarts such as Casper have revolutionized how consumers purchase mattresses—online out of a box. Premium non-innerspring (air, memory foam) models are selling well.
- CPAP devices (Continuous Positive Airway Pressure) – This is a $4.3 billion market that’s growing 7.2% a year. It is dominated by ResMed and Respironics. The market is largely untapped – only 12% penetrated in the U.S.. It has major potential, as more people, especially the obese, are diagnosed with obstructive sleep apnea.
- The sleep pillows market is worth $1.6 billion and is also growing, as new materials and premium-priced pillows enter the market.
View a Table of Contents for this report, “The Sleep Market“, April 2018, at: marketdataenterprises.comn/studies.
Purchase it (report FS 34) at our website, here:
marketdataenterprises.com/reports/